The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZinnwald Lithium Regulatory News (ZNWD)

Share Price Information for Zinnwald Lithium (ZNWD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.15
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.30 (4.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.15
ZNWD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

25 Apr 2023 10:00

RNS Number : 2277X
Zinnwald Lithium PLC
25 April 2023
 

Zinnwald Lithium plc / EPIC: ZNWD.L / Market: AIM / Sector: Mining

25 April 2023

Zinnwald Lithium plc

("Zinnwald Lithium" or the "Company")

 

Appointment of Non-Executive Director

 

Zinnwald Lithium plc, the German focused lithium development company, is pleased to announce the appointment of Dr. Stefan Scherer as a Non-Executive Director in accordance with the terms of the Relationship Agreement with AMG Advanced Metallurgical Group N.V. ("AMG") announced on 22 March 2023.

 

As Chief Executive Officer of AMG Lithium GmbH and Chief Commercial Officer of AMG Lithium BV, Dr. Scherer is responsible for AMG's downstream Lithium business as well as the overall strategy development for its entire Lithium operations. After his studies in chemistry at the Technische Hochschule Darnstadt, Dr. Scherer completed his PhD in Organic Chemistry at the Goethe University in Frankfurt in 1995. He has more than 20 years' experience in the speciality and fine chemical industries in various R&D, operational and management positions, including periods with Albermarle and Rockwood Lithium/Chemetall, prior to joining AMG in 2019. Dr. Scherer is a German citizen.

 

Zinnwald Lithium CEO, Anton du Plessis, said: "We are delighted to welcome Dr. Stefan Scherer to the Board. He brings significant lithium industry experience that will be extremely relevant to our advanced integrated lithium hydroxide project located in Saxony and a wealth of contacts within the German business community, which will be invaluable as we move forward."

 

Disclosures under Schedule 2 of the AIM Rules

Dr. Scherer, aged 55, holds or has held the following directorships and/or partnerships in the previous five years.

 

Present Directorships / Partnerships

Past Directorships / Partnerships

AMG Lithium GmbH (Germany)

AMG Lithium B.V. (Netherlands)

Albermarle Germany GmbH

 

Dr. Scherer does not directly hold any shares nor options over ordinary shares in the Company. He is the appointed representative of AMG, which owns 25.1% of the Company.

 

There is no further information which is required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies in respect of Dr. Scherer.

 

*ENDS*

 

 For further information visit www.zinnwaldlithium.com or contact:

 

Anton du Plessis

Cherif Rifaat

Zinnwald Lithium plc

info@zinnwaldlithium.com

David Hart

Dan Dearden-Williams

Allenby Capital

(Nominated Adviser)

+44 (0) 20 3328 5656

Michael Seabrook

Adam Pollock

Oberon Capital Ltd

(Joint Broker)

+44 (0) 20 3179 5300

Richard Greenfield

Charles Bendon

Tamesis Partner LLP

(Joint Broker)

+44 (0) 20 3882 2868

Isabel de Salis

Paul Dulieu

St Brides Partners

(Financial PR)

zinnwald@stbridespartners.co.uk

 

 

Notes

AIM quoted Zinnwald Lithium plc (EPIC: ZNWD.L) is focussed on becoming an important supplier of lithium hydroxide to Europe's fast-growing battery sector. The Company owns 100% of the Zinnwald Lithium Project in Germany, which has an approved mining licence, is located in the heart of Europe's chemical and automotive industries and has the potential to be one of Europe's more advanced battery grade lithium projects.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUGCUPWUBC
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSFinal Results
7th Mar 20247:00 amRNSOperational Update
21st Feb 20247:00 amRNS445% Increase in Mineral Resource Estimate
31st Jan 20246:15 pmRNSTotal Voting Rights
15th Jan 20247:00 amRNSShare Incentive Awards and Vesting of RSUs
21st Dec 20237:00 amRNSMineral Resource Estimate Update
17th Oct 20238:00 amRNSZinnwald And Metso Advance Joint Testwork Program
17th Oct 20237:00 amRNSOperational Update
24th Aug 20237:00 amRNSInterim Results
6th Jul 20237:00 amRNSGrant Of Additional Exploration Licence
14th Jun 20237:00 amRNSOperational & Corporate Update
13th Jun 202310:24 amRNSResult of AGM
8th Jun 20237:00 amRNSInvestor Presentation
15th May 20237:00 amRNSNotice of AGM
25th Apr 202310:00 amRNSAppointment of Non-Executive Director
6th Apr 20232:44 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSHolding(s) in Company
29th Mar 20232:42 pmRNSHolding(s) in Company
29th Mar 202312:32 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSPresenting at Battery Gigafactories Europe 2023
23rd Mar 20232:05 pmRNSSecond Price Monitoring Extn
23rd Mar 20232:00 pmRNSPrice Monitoring Extension
23rd Mar 20238:11 amRNSIssuance of RSUs and Options
23rd Mar 20237:58 amRNSResult of fundraising
22nd Mar 20235:02 pmRNSRetail offer via PrimaryBid
22nd Mar 20235:01 pmRNSStrategic Investment and Equity Fundraising
22nd Mar 20235:00 pmRNSFinal Results
13th Mar 20237:00 amRNSOcean Partners UK Ltd to acquire Erris Zinc Ltd
23rd Feb 20233:00 pmRNSHolding(s) in Company
21st Feb 20234:40 pmRNSSecond Price Monitoring Extn
21st Feb 20234:35 pmRNSPrice Monitoring Extension
6th Feb 20237:00 amRNSTamesis as Joint Broker & Research Published
30th Jan 20237:00 amRNSPotential for Significant Li Resource @ Falkenhain
23rd Nov 20227:00 amRNSOperational Update
1st Nov 20227:00 amRNSMOU to develop sustainable mining operation
15th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNew Corporate Presentation
9th Sep 20224:00 pmRNSInvestor Presentation
9th Sep 20223:39 pmRNSHolding(s) in Company
8th Sep 20221:00 pmRNSHolding(s) in Company
7th Sep 20227:00 amRNSPEA - Robust Economics for German Lithium Project
5th Sep 20227:00 amRNSStart of Exploration Drilling at Falkenhain
4th Aug 20227:00 amRNSOption to Acquire Land
27th Jul 20227:00 amRNSStart of Drilling
23rd Jun 202211:37 amRNSResult of AGM
8th Jun 20227:00 amRNSOperational Update
7th Jun 20224:59 pmRNSHolding(s) in Company
26th May 20227:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.